Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001082554-25-000023
Filing Date
2025-04-30
Accepted
2025-04-30 06:32:05
Documents
78
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q uthr-20250331.htm   iXBRL 10-Q 1570176
2 EX-31.1 uthrex31103312025.htm EX-31.1 11941
3 EX-31.2 uthrex31203312025.htm EX-31.2 11947
4 EX-32.1 uthrex32103312025.htm EX-32.1 6647
5 EX-32.2 uthrex32203312025.htm EX-32.2 6774
  Complete submission text file 0001082554-25-000023.txt   7819066

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT uthr-20250331.xsd EX-101.SCH 44567
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT uthr-20250331_cal.xml EX-101.CAL 70846
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT uthr-20250331_def.xml EX-101.DEF 238257
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT uthr-20250331_lab.xml EX-101.LAB 656180
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT uthr-20250331_pre.xml EX-101.PRE 454092
81 EXTRACTED XBRL INSTANCE DOCUMENT uthr-20250331_htm.xml XML 1166140
Mailing Address 1000 SPRING ST SILVER SPRING MD 20910
Business Address 1000 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Filer) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26301 | Film No.: 25890755
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)